About BIOTRONIK

For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that transform the lives of millions affected by heart disease and chronic pain.

Rooted in a deep purpose to harmonize technology with the human body, we engineer trusted, life-changing therapies across Cardiac Rhythm Management, Monitoring, Neuromodulation and Electrophysiology.

Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA and Asia.

Innovation in practice

Technology built around better outcomes

MRI Guard 24/7

Automatically detects the MRI field and reprograms the device to MRI settings during the procedure.

Streamlines workflow for MRI patients

Smart ECG

Utilizing AI technology in BIOMONITOR IV to improve clinician workflow efficiency.

Reduces false alert burden by 86%⁴

Battery Longevity

Battery capacity drives battery longevity.

Industry-leading ICD and CRT-D battery chemistry¹

DX Technology

Improved patient outcomes over SC-ICD.

Accurate detection without atrial lead complications^5–9

Physiologic Pacing

Giving heart rate control back to the patient's autonomic nervous system.

Closed Loop Stimulation (CLS)

HeartInsight

A multiparameter heart failure score for actionable prediction and proactive care.

Staying one step ahead of heart failure

LBBAP Delivery

Solia CSP & Selectra 3D is the first dedicated lead and catheter combination specifically engineered for LBBAP.

Support and deliverability in one platform

EggNest^™

Protection for everyone in the lab.

Radiation reductions up to >99%¹²

BIOTRONIK Home Monitoring^®

The only remote monitoring system with automatic daily transmissions.

Early detection and lower mortality rates^10,11

Hauser RG, et al. J Interv Card Electrophysiol. 2021 Dec;62(3):507-518.
Data on file. As of July 2024.
BIOTRONIK Solia S, Selectra 3D technical manuals. Abbott CPS Locator 3D manual; Boston Scientific Ingevity+, SSPC Catheter manuals.
BIOTRONIK data on file. With AF filtering criterion set to Very specific in the Home Monitoring Service Center. Sensitivity is relative to performance without SmartECG.
Thomas G et al. J Cardiovasc Electrophysiol. 2019 Oct;30(10):1994-2001.
Hindricks G et al. Europace. 2023 May 19;25(5):euad061.
Reynolds M et al. J Am Coll Cardiol. 2006 Jun, 47 (12) 2493–2497.
Dewland TA et al. J Am Coll Cardiol. 2011 Aug 30;58(10):1007-13.
Margolis G et al. J Am Heart Assoc. 2023 Aug;12(15):e029126.
Hindricks G et al. Lancet. 2014 Aug 16;384(9943):583-590.
Varma N et al. Circulation. 2010 Jul 27;122(4):325-32.
Riley, R, Kamen, J, Tao, A. et al. 800.01 Comparative Effectiveness of the EggNest Complete Shielding System to Standard Shielding in the Cath Lab. J Am Coll Cardiol Intv. 2025 Feb, 18 (4_Supplement) S83. https://doi.org/10.1016/j.jcin.2025.01.313